2008
DOI: 10.1097/00042728-200805000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Applicability of in vivo Reflectance Confocal Microscopy for the Diagnosis of Actinic Keratoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
115
0
3

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(123 citation statements)
references
References 24 publications
5
115
0
3
Order By: Relevance
“…Later, others confirmed the usefulness of this tool [73,[88][89], although it has not been able to unequivocally differentiate actinic keratosis from squamous cell carcinomas [90]. Non-melanoma skin cancers (NMSC) were evaluated by fluorescence confocal microscopy aiming to diagnose and monitor the lesions in reference to normal skin and correlation with routine histology.…”
Section: Crm and Non-melanocitic Lesionsmentioning
confidence: 99%
“…Later, others confirmed the usefulness of this tool [73,[88][89], although it has not been able to unequivocally differentiate actinic keratosis from squamous cell carcinomas [90]. Non-melanoma skin cancers (NMSC) were evaluated by fluorescence confocal microscopy aiming to diagnose and monitor the lesions in reference to normal skin and correlation with routine histology.…”
Section: Crm and Non-melanocitic Lesionsmentioning
confidence: 99%
“…One of the most informative is in vivo reflectance confocal microscopy (RCM), which provides real-time optical transversal sections 1 of the skin area of interest, giving diagnostic information that, in some cases, parallels that of histology and has been recently summarized in these reviews. 2,3 The transversal sections can be acquired at sequential depths with an axial resolution of 3 to 5 μm and arranged in image stacks that document the three-dimensional skin architecture. 4 In most cases, analysis of the image stacks or individual optical slices is done manually.…”
Section: Introductionmentioning
confidence: 99%
“…noma skin cancer (1)(2)(3)(4)(5)(6)(7)(8)(9)(10). It is also used for in vivo and ex vivo evaluation of nondermatological diseases such as neoplasia of mucosal tissues from mouth and cervix, mammary glands and neural tissue (11)(12)(13)(14).…”
mentioning
confidence: 99%